the short story project


Mirabegron 50mg Tablet

Zantac, Pregnancy, and Birth Defects

The medications that a person can take when pregnant are few. For many years, Zantac made its way onto this list. As a result, expecting mothers who experienced heartburn during pregnancy did not hesitate to reach for Zantac. This decision was motivated in part because Zantac has long been classified as a Category B drug by the Food and Drug Administration. Drugs in this category are considered safe for developing fetuses.

Recent Food and Drug Administration studies, however, have found increasing evidence that the drug should no longer fall in this classification. Instead, if an expecting mother took Zantac for any reason during pregnancy, the child is at risk of developing a birth defect or cancer. 

Understanding the Role of Zantac

Zantac is the most popular brand name of the Ranitidine drug. Zantac 300mg Tablets that is used to manage the symptoms of acid reflux and heartburn. Zantac was first sold in the United States in 1983 and promptly gained widespread use. Zantac was even the first medication to surpass $1 billion in sales and currently has annual sales of $129 million. 

The Zantac Recall

In April 2020, the Food and Drug Administration issued a market-wide recall of Zantac. The recall applies to both prescription and over the counter (OTC) versions of the medication. While most people have heard something about the Zantac recall, many still have questions about the medication. If you have questions about any medications that you took, you should contact your pharmacist and ask them to explain what drugs are found in the medication. If the pharmacist lists Ranitidine, you should not hesitate to speak with a knowledgeable defective drug attorney. 

Current FDA research has determined that both Zantac and the generic form of Zantac are broken into the NDMA carcinogen while the medication is still in its packaging. Additionally, research has determined that Zantac also breaks down into NDMA after a person has taken the medication. Prolonged usage of either ranitidine or Zantac can place a person to elevated levels of NDMA, which can lead to cancer in pregnant women as well as birth defects in unborn children.

Possible Birth Defects Associated with Zantac Usage
Several types of birth defects are associated with prolonged usage of ranitidine or Zantac during pregnancy. While there are many potential defects, some of the most common birth defects associated with exposure to NDMA include:

Chef palate
Heart murmurs
Neonatal deaths
Postnatal cancer
Qualifying Factors for Zantac or Ranitidine Compensation
If your pregnancy resulted in a birth defect after taking ranitidine or Zantac or you or your child developed cancer after prolonged usage of these medications, you might be able to pursue compensation. If you satisfy the following criteria, you will likely be able to obtain compensation:

You have taken ranitidine or Zantac for a minimum of six months during pregnancy
You took a minimum of 300 mg/week of ranitidine or Zantac during six months of pregnancy
You experienced a birth defect
There are no more than five years between the birth and diagnosis of the condition.


Read More